News

H-D Feminine Health, announces it has initiated the first randomized, placebo-controlled, double-blinded Phase 3 clinical trial cleared to proceed by the U.S. Food and Drug Administration (FDA) to ...
Nigerian Exchange Group (NGX Group), Health Emergency Initiative (HEI) and Lagos State Government have launched a joint ...
Monopar Therapeutics Inc. ('Monopar” or the 'Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, ...
Monopar Therapeutics Inc. ("Monopar" or the "Company") (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments ...
New federally funded research on the relationship between post-traumatic stress disorder and cannabis use in military ...
Tividenofusp alfa BLA for Hunter syndrome accepted for priority review and assigned PDUFA target action date of January 5, 2026; company preparing for commercial launchDNL126 accelerated approval path ...
Clinical Trials of Budoprutug in Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE) Underway; ...
Billy Bragg will host 'Days Like These', a special benefit concert for Amos Trust's Gaza appeal at the O2 Shepherd's Bush Empire in London on Saturday 20 September.
A phase 3 study shows Cylembio combined with pembrolizumab improves progression-free survival in advanced melanoma, ...
Psychedelics are increasingly being studied as wonder medicines for psychiatric issues like depression and even addictions to ...